Home
Latest Filings
Latest Buys
Latest Sells
Institutions
Derivatives
Hot Buys
Data Screener
Email Alerts
Insider Charts
NTLA
- As of 05/14/24, 05:00:03 AM: 17 Insider Transactions.
Sector:
Unknown
Industry:
Unknown
Prev Close:
$19.93
Avg Vol(3m):
418,220
P/E:
0.00
EPS:
-69.20
Email this page to a friend.
Insider Transactions for NTLA
Buy/Sell*
Filed Date
Subject
Symbol
Acquirer
Pct Owned
Details
S
2020-08-20 16:30:13.0
Intellia Therapeutics
NTLA
Novartis Institutes for BioMedical Research
7.4%
view
S
2020-02-14 11:43:08.0
Intellia Therapeutics
NTLA
ARK Investment Management LLC
3.46%
view
B
2020-02-12 17:24:15.0
Intellia Therapeutics
NTLA
Nikko Asset Management Americas
7.2%
view
S
2020-02-12 06:06:28.0
Intellia Therapeutics
NTLA
FMR LLC
0.324%
view
B
2019-08-08 06:02:31.0
Intellia Therapeutics
NTLA
Sumitomo Mitsui Trust Holdings
14.09%
view
B
2019-07-09 08:53:31.0
Intellia Therapeutics
NTLA
Nikko Asset Management Americas
2.05%
view
S
2019-07-09 06:11:46.0
Intellia Therapeutics
NTLA
Caribou Biosciences
4.0%
view
B
2019-02-14 11:32:40.0
Intellia Therapeutics
NTLA
STATE STREET CORP
5.3%
view
S
2019-02-11 15:15:54.0
Intellia Therapeutics
NTLA
Atlas Venture Fund IX
3.72%
view
S
2019-02-07 18:10:26.0
Intellia Therapeutics
NTLA
BlackRock Inc
5.8%
view
S
2018-03-23 17:27:52.0
Intellia Therapeutics
NTLA
Novartis Institutes for BioMedical Research
4.99%
view
S
2018-02-13 09:39:49.0
Intellia Therapeutics
NTLA
FMR LLC
8.45%
view
B
2018-02-06 16:07:13.0
Intellia Therapeutics
NTLA
Caribou Biosciences
5.99%
view
S
2017-12-14 12:29:18.0
Intellia Therapeutics
NTLA
ORBIMED ADVISORS LLC
5.99%
view
B
2017-02-14 11:25:00.0
Intellia Therapeutics
NTLA
Atlas Venture Fund IX
12.3%
view
B
2016-06-10 08:42:26.0
Intellia Therapeutics
NTLA
ORBIMED ADVISORS LLC
7.4%
view
B
2016-05-11 16:09:42.0
Intellia Therapeutics
n/a
REGENERON PHARMACEUTICALS INC
15.48%
view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.